Team Project

High Promoter Methylation Levels of APC Predict Poor Prognosis in Sextant Biopsies from Prostate Cancer Patients

High Promoter Methylation Levels of APC Predict Poor Prognosis in Sextant Bx in Prostate CA Patients
483
APC, CCND2, GSTP1, RARB2 and RASSF1A
No design specified.
UNKNOWN
Prostate and Urologic Cancers Research Group
1

see publication

see publication
see publication

There are currently no biomarkers annotated for this protocol.

No datasets are currently associated with this protocol.


Version 5.0.3